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3Abstract47
INTRODUCTION: Patients with rheumatoid arthritis (RA) present higher incidence48
and severity of periodontitis than the general population. Our study, Outcomes of49
Periodontal Treatment in Patients with Rheumatoid Arthritis (OPERA) was a50
randomized waiting-list-controlled trial using mixed methods. Patients randomized51
to the intervention arm received intensive periodontal treatment and those in the52
control arm received the same treatment with a six months delay.53
AIM: The nested qualitative component aimed to explore patient’s experiences and54
priorities concerning oral health and barriers and facilitators for trial participation.55
METHODS: Using purposive sampling until thematic saturation was reached, we56
conducted 21 one-to-one semi-structured interviews with randomized patients in57
either of the two treatment arms as well as with patients who did not consent for trial58
participation.59
RESULTS: The patients described their experiences about RA, oral health and study60
participation. Previous experiences with dental care professionals shaped patients’61
current perceptions about oral health and the place of oral health on their list of62
priorities when compared with other conditions. Patients also highlighted some of63
the barriers and facilitators for study participation and for compliance with oral health64
maintenance. The patients, in the control arm, presented their views regarding the65
acceptable length of waiting time for the intervention. CONCLUSION: The66
associations between periodontal and systemic health are increasingly recognised67
4by the literature. Our study provided an insight into RA patients’ experiences and68
perceptions about oral health. It also highlighted some of the barriers and facilitators69
for participating in a periodontal interventional study for this group. We hope that our70
findings will support the design of larger interventional periodontal studies in patients71
with rheumatoid arthritis. The complex challenges faced by the burden of RA and72
the associated multimorbidities in this patient group might highlight opportunities to73
improve access to oral health services in this patient population.74
5INTRODUCTION75
Chronic periodontitis is a very common chronic inflammatory condition. It affects76
nearly half of the UK adult population and over 60% of the elderly (Chapple 2014;77
White et al. 2012). Several observational studies have reported an association78
between chronic periodontitis and rheumatoid arthritis (RA) and chronic periodontitis79
has been suggested as a potential risk factor for RA (de Pablo et al. 2009; Konig et80
al. 2016; Mikuls et al. 2009; Okada et al. 2013; Ribeiro et al. 2005). Given the high81
prevalence of chronic periodontitis, this association could have significant clinical82
and public health implications.83
The first symptoms of RA are noticed usually between the age of 35 and 50 and it84
affects mostly women. Within 5 years of diagnosis, 40% of patients reduce their85
working week from full time to part time, with an increase to 50% at 10 years from86
the first diagnosis (Mathers and Pfleger 2006). Rheumatoid arthritis affects patients’87
personal and professional relationships transforming their daily routines and quality88
of life. Often they have to change their working circumstances or retire early, adapt89
their living conditions, rely on help from external sources (family, friends or social90
workers) and increase their feeling of vulnerability which is added as a psychological91
burden to their condition (Lapsley 2002).92
Besides the direct impact of RA on patients’ quality of life, it is important to consider93
also the indirect impact caused by the comorbidities secondary to RA and the side94
effects of the long-term use of polypharmacy in this patient group.95
6RA has been frequently associated with other conditions including depression,96
elevated blood pressure, cardiovascular disease and respiratory conditions.97
(Dougados et al. 2014).98
There are several potential mechanisms linking RA and periodontal disease. Some99
studies have suggested that bacteraemia caused by periodontal pathogens could be100
an etiological agent for RA progression (Martinez-Martinez et al. 2009).101
Another widely supported model relates to an aberrant immune response to102
periodontal pathogens in certain susceptible individuals.  One of the main103
periodontal pathogens is Porphyromonas gingivalis. With the recent recognition of104
the importance of anti-citrullinated protein antibodies (ACPA) in RA and the105
discovery that P. gingivalis expresses peptidyl arginine deiminase which is106
responsible for the post-translational citrullination of peptide antigens on arginine107
residues (Rosenstein et al. 2004), there is potential evidence to support a plausible108
pathobiologic mechanism by which periodontitis may cause or sustain the ACPA109
response in RA.110
Recent studies have also demonstrated that the uncitrullinated peptides play a major111
role in the antibody response for periodontitis resulting in a systemic spread of112
citrullinated epitopes in the presymptomatic phase of RA. Autoantigens modified by113
citrullination through exposure to periodontal pathogens might sustain synovial114
inflammation in the context of untreated periodontitis (Lopez-Oliva et al. 2018;115
Rosenstein et al. 2004). Antibodies for uncitrullinated RA autoantigens precede the116
ACPA formation and facilitate the loss of tolerance to uncitrullinated peptides (de117
Pablo et al. 2013).118
7Treatment of chronic periodontitis involves control of the dental biofilm, typically119
using non-pharmacological means. Whether or not such treatment can reduce the120
incidence and severity of RA is unknown. However, a small number of interventional121
studies have reported encouraging results in terms of reduced RA disease activity122
following periodontal treatment (Al-Katma et al. 2007; Okada et al. 2011; Ortiz et al.123
2009).124
Our trial, Outcomes of Periodontal Treatment in Patients with Rheumatoid Arthritis125
– OPERA, was a randomized waiting list controlled feasibility study. This trial126
provides feasibility data for a larger, multi-centre randomized controlled trial, which127
would investigate the efficacy of non-surgical periodontal treatment in reducing128
disease activity in patients with RA.129
Our trial focussed on issues of recruitment and retention, acceptability and feasibility130
of the trial procedures including the intervention, assessments and data collection,131
using a mixed methods approach. The quantitative component of our trial gathered132
pilot clinical data about the efficacy of periodontal treatment in patients with RA and133
subsequently its influence on health-related quality of life.134
Considering the severe burden that RA can have on the patient’s quality of life, both135
directly and through the comorbidities associated with this condition, it is important136
to gain a better understanding of patients’ priorities with regards to accessing137
different types of health care services. Additionally, it is important to ensure that the138
design of any interventional studies would take this into account and patients’ trial139
participation would not create an additional burden on their quality of life. As140
successful periodontal treatment is heavily dependent on compliance and141
8adherence and the treatment and trial participation both require multiple visits to the142
secondary care setting where this treatment was being delivered we considered143
important to explore the barriers and facilitators for study participation in this patient144
group.145
Furthermore, in order to encourage recruitment and retention rates in the trial, it is146
important to consider that outcomes that are relevant for clinicians and researchers147
might be less relevant for the patients. This could be especially the case for RA148
patients with multimorbidities as suggested in the literature (Cohen et al. 2004;149
Fleischmann et al. 2016). Understanding the health care priorities of this specific150
patient population and the place of oral health on their list of priorities was one of the151
most important objectives of the qualitative component of our study.152
Our study used a mixed method approach with a quantitative and a nested153
qualitative component. The quantitative aspects of the trial will be presented in detail154
in a separate paper. This paper focuses on the nested qualitative component of this155
study.156
Aims and objectives157
The aim of the qualitative component of our study was to evaluate patients’158
experiences, values and priorities that shape their choices in accessing oral health159
services and identify the barriers and facilitators for participation in a randomized160
controlled trial. In order to meet this aim, we developed the following objectives: 1.161
Understand the impact of RA on the patient’s quality of life and the place that oral162
health occupies on their scale of health priorities; 2. Identify barriers and facilitators163
9for study participation; 3. Understand RA patients’ views about randomisation to the164
intervention or control group (delayed intervention).165
METHODS166
The OPERA trial recruited patients with RA, fulfilling the revised 1987 ACR167
classification criteria for RA (Aletaha et al. 2010). The recruitment sites were the168
outpatient rheumatology clinics of the Queen Elizabeth Hospital (QE), City Hospital169
and Heartlands Hospital all in Birmingham, U.K.170
A total of 691 RA patients were identified as potential participants from the three171
recruitment sites. Of these, 118 declined participation in the trial predominantly due172
to the severity of their comorbidities and the numerous medical appointments that173
they already have to attend.174
Of these, 296 patients consented to participate in the trial and 201 attended the175
periodontal screening visit at Birmingham Dental Hospital. Of these, 60 met both the176
RA and periodontal criteria for randomization and were allocated to either immediate177
intervention or waiting list control (delayed intervention) group (Figure 1). The178
intervention consisted of non-surgical periodontal therapy delivered by a dental179
hygienist in two or more sessions in a secondary care setting.180
PLEASE INSERT FIGURE 1181
Study oversight182
Ethical approval for the OPERA trial was granted (11/WM/0235, protocol number183
RG_10-138 and registered via the Integrated Research Application System (IRAS)184
with project ID 53163.185
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Recruitment186
The recruitment for the trial started in January 2014 and data collection ended in187
December 2016.  Research and development (R&D) approval was obtained for all188
the participating sites.189
Some of the inclusion criteria for the periodontal screening were, among others,190
fulfilment of 2010 ACR/ EULAR classification criteria of RA (Aletaha et al. 2010) and191
stable medication. For randomization, patients had to have a disease activity score192
(DAS28) of at least 3.2 and generalized moderate to severe chronic periodontitis as193
evidenced by pocketing with clinical attachment loss (clinical attachment loss  4194
mm on at least 2 non-adjacent teeth and cumulative probing depth 40mm).195
For exclusion criteria, we considered history of, or current, inflammatory joint disease196
other than RA (including, but not limited to, gout, reactive arthritis, psoriatic arthritis,197
seronegative spondyloarthropathy); any surgical procedure including bone/joint198
surgery/synovectomy (including joint fusion or replacement) within 12 weeks prior to199
baseline or planned during study and periodontal treatment within 12 months prior200
to baseline.201
A detailed description of the clinical methodology and findings will be reported in a202
separate paper.203
Screening204
Patients were approached for consent during their rheumatology follow-up205
appointments at the participating hospitals. After consenting, clinical rheumatologic206
data were collected and a screening appointment was offered at the OPERA207
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research clinic at Birmingham Dental Hospital. As some patients expressed an208
unwillingness to participate because of the logistic difficulties in getting to the Dental209
Hospital, further assistance was offered with transportation to these patients.210
Reminder letters with the appointment date and time for the Screening visit were211
sent out by post to each newly booked patient. One or two days before the212
appointment, a research nurse called the patients to remind them of their213
appointment.214
At Birmingham Dental Hospital, patients were assessed in a dedicated clinic215
available for OPERA trial patients. This involved general clinical examination,216
rheumatologic assessment including the disease activity score 28 (DAS28), full217
mouth probing, and biological sample collection.218
Randomization and follow-up219
If patients fulfilled the eligibility criteria for randomization and treatment, they were220
offered participation in the interventional phase of the study. After consenting for221
randomization and treatment, patients were randomly allocated to either immediate222
treatment or delayed treatment (waiting list control). For the patients allocated to the223
immediate treatment arm, three appointments were booked with a dental hygienist224
allocated for this project at maximum of three weeks after the Screening visit.225
Patients in the delayed treatment arm had one appointment with the same hygienist226
for instructions on oral health maintenance.227
The same clinical examinations were carried out at the follow-up visits as at baseline.228
The patients allocated to the delayed treatment group were offered three229
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appointments with the same dental hygienist for periodontal treatment at the end of230
the study. All the patients, at the end of the study received £150 to cover the possible231
costs regarding their commitments for study participation. Most patients who did not232
wish to consent for screening were offered the possibility to participate in the233
qualitative interview process, either face to face or over the telephone. Inviting234
patients who did not consent to take part in the clinical trial to participate in the235
qualitative interviews was particularly important to meet our aims and objectives in236
identifying barriers and facilitators for study participation.237
Sample Selection238
For the purposes of the qualitative component of this study, we used a purposeful239
sampling technique aimed to include a variety of patients and to ensure broad240
representation of views relevant to the various aspects of study participation. We241
therefore invited patients who:242
x Had declined to consent for the clinical intervention243
x Were screened but were not eligible for randomization for the clinical244
intervention245
x Were randomized to the immediate periodontal treatment group246
x Were randomized to the control group247
x Were representing gender diversity248
x Presented different lengths of time since diagnosis (RA)249
One to one, semi-structured interviews were conducted with patients from all these250
groups until thematic saturation was reached. As new themes emerged from the251
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discussions, the topic guide was constantly adapted and new themes were added252
until saturation was reached. Saturation was defined as the stage at which no new253
themes emerged from the interviews and the data started to become mainly254
repetitive. After saturation, three more interviews were conducted for quality255
assurance purposes. All interviews were carried out by the same researcher to256
ensure consistency. All interviews were recorded and fully transcribed. The first five257
interviews were conducted by a dentist under the supervision of an expert in258
qualitative research (psychologist). The interviews were conducted at Birmingham259
Dental Hospital, Queen Elizabeth Hospital Birmingham and over the telephone260
between October 2014 and January 2016 and lasted on average 30 minutes. Sixteen261
interviews were conducted face to face and five over the telephone. Some262
participants preferred to have the interview conducted over the telephone for263
convenience, especially those who did not wish to consent for trial participation. In264
relation to the other aspects of the study, the first patient was screened in February265
2014 and the last patient was randomized in October 2015.266
Topic guide267
The initial topic guide developed by the research team included: oral health268
maintenance, treatment preferences (dental and medical), access to dental care,269
priorities and values placed on oral health, quality of life issues, acceptability of the270
periodontal treatment and, if applicable, reasons for non-participation. This initial271
topic guide was piloted with three patients who consented to participate. The piloting272
phase was developed and implemented by the research team to ensure273
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methodological accuracy of the interview process. The results of these three274
interviews were included in the overall findings.  Based on the dynamics of the275
discussions and the flexible structure of the interviews, new themes emerged that276
were incorporated in the topic guide and added to the interviews with subsequent277
participants.278
Data analysis and validation279
A framework approach to data analysis was adopted in the manner suggested by280
Pope et al. (Pope and Mays 2006). The framework was developed using the topic281
guide and additional columns were added to the framework as new themes emerged282
from the interviews. One researcher (dentist) carried out the interviews and the283
analysis in order to assure consistency and robustness. The transcripts were read284
and analysed independently by a second researcher (psychologist) following NICE285
guidelines (Tan et al. 2009). The two researchers discussed and reached consensus286
of the findings. A third independent researcher was available to oversee the findings287
in case a consensus was not reached.288
RESULTS289
Patient demographics290
21 participants (15 females, 6 males) with a median age of 60 years were interviewed291
to participate in the interviews (Table 1).292
RA disease duration ranged from 1 year to 60 years (median 19 years). More than293
half of the participants (n=13) had consented for periodontal screening in the study,294
while the remaining participants did not (n=8) (Table 1).295
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Table 1 Demographic characteristics of participants in the qualitative component296
Pt # Gender Age Years since
diagnosis
Patient group
1 F 60 19 Randomized - delayed
2 M 86 20 Refused trial participation
3 F 83 60 Refused trial participation
4 F 37 9 Refused trial participation
5 M 52 13 Randomized - delayed
6 F 59 20 Refused trial participation
7 F 68 22 Refused trial participation
8 M 65 30 Randomized - delayed
9 F 60 67 Refused trial participation
10 F 65 6 Randomized - delayed
11 F 55 12 Randomized - immediate
12 F 59 2 Refused trial participation
13 M 54 14 Refused trial participation
14 M 64 10 Not eligible for randomization
15 F 62 36 Randomized - delayed
16 F 47 15 Randomized - delayed
17 F 61 15 Randomized - delayed
18 F 62 25 Randomized - immediate
19 F 62 30 Randomized - delayed
20 M 57 20 Randomized - immediate
21 F 57 1 Randomized - immediate
Median [IQR] 60 [57,64] 19 [12,25]
297
The main emerging themes from the framework analysis are presented in Figure 2.298
These can be clustered into three main areas: “RA and quality of life”, “Oral health”299
and “The Study”.  The new topics that emerged from the discussions were related to300
patients’ perceptions of oral health and their previous experience with dental care301
professionals. Furthermore, the patients elaborated on their health priorities,302
perceived barriers for study participation and potential solutions for the removal of303
those barriers.304
PLEASE INSERT FIGURE 2305
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Rheumatoid arthritis and quality of life306
Discussions started with participants describing their experiences regarding the307
onset and subsequent history of their RA and the effect it had on their quality of life.308
All participants described the onset of their condition as highly distressing.309
“I remember going to pick my son up from school and walking up the high310
street and just with tears rolling down my face because I was in such pain…311
I had never known anything like it and then it just got worse from there…312
Everyday things that I would have done without blinking an eye just became313
totally impossible to do because I had no grip in my hands, no strength then314
to actually get myself up in the bed.” (P1)315
Each story carried a vivid and painful memory associated with anxiety and distress316
as patients and their families struggled to understand what was happening:317
"The children thought I was going to die.  I heard them talking to my wife and318
they said “Is dad going to die?” and I though, blimey, I must look bad, but I319
was so thin me bones were sticking out all over the place.” (P14)320
Some of the patients shared their stories about the impact that RA had on their work321
and socio-economic status. In some cases, this went as far as the patients having322
to change their living arrangements and make compromises in order to find ways to323
adapt to their new situation.324
“I did retire early yes as a consequence and I had to give my home up325
because I couldn’t get up the stairs any more… So, within a very short326
space of time from 2010 to 2014 I retired early and I lost my home… I am327
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living in a bungalow now, which has been adapted for my needs. I’ve got328
a wet room as opposed to a bathroom.” (P10)329
The majority of patients mentioned that they had taken early retirement or had to330
reduce their work schedule from full-time to part-time because of the impact of RA331
on their work life. Patients reported that this had a major negative impact on their332
socio-economic status.333
Besides work, RA also affected the ability of patients to enjoy their hobbies and334
social activities.335
“I used to enjoy football, fishing, things like that.  I couldn’t go fishing cos336
I couldn’t hold the rod any longer in that one position holding the rod.”337
(P20)338
As the discussions developed around the traumatizing experiences caused by the339
onset of RA, the patients started to describe also the challenges represented by340
several comorbidities that they had to deal with.341
Comorbidities and health priorities342
As the average age of the participants was around sixty years, comorbidities343
associated with RA were common. In order to gain a better insight into the reasons344
why they might or might not participate in the study, it was important to understand345
their health care priorities and the impact of their comorbidities and how they346
prioritize the health care services that they are accessing.  Another factor was to347
understand where oral health was situated on their list of health care priorities.348
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Although, several patients declared oral health as a priority in the beginning of the349
interview, as the discussions evolved and they reported on comorbidities, they350
presented a tendency to prioritise other comorbidities compared to oral health:351
“So, I have rheumatoid arthritis and I have asthma/COPD, so I have breathing352
problems, but again somebody is looking after me... And that is linked to what353
used to be a constant round of chest infections, but they now seem to have354
this under control and then oral health is the third most important thing in my355
life. “(P9)356
Patients’ numerous different hospital appointments represent a burden to some of357
the patients and the dental care occasionally tends to become less of a priority:358
"No, no I probably haven’t been to the dentist, it has got to be a year now, so359
but part of that is that I have so many appointments for different things at the360
moment, that unless I am reminded of an appointment, or given an361
appointment they tend to slip away." (P5)362
As most of the patients had multiple comorbidities, some of them tended to place363
oral health as the last one on the scale of importance. Their main priorities were364
systemic conditions including RA itself, cardiovascular disease, Crohn’s disease,365
asthma, chronic obstructive pulmonary disease (COPD), diabetes, etc.366
“My chest really, my chest is first then my rheumatoid. My teeth, round about367
third I think to be honest.” (P7)368
“But the other thing to remember is for patients like me who have got369
rheumatoid, they’ve probably got other ongoing conditions as well.  There is370
so many things you have to try and focus on." (P4)371
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In light of these, some patients reported that they would prefer to have their teeth372
extracted rather than have multiple appointments for conservative treatment:373
"If I had to have teeth out, I have to have them out and that’s the end of it.”374
(P4)375
Periodontitis and oral health376
Discussions focused on patients’ perceptions about oral health, their self-reported377
oral health status and previous experience that they had had with dental care378
professionals. Few participants reported having a good oral health status. Their past379
experiences regarding oral health care services shaped their perception regarding380
their current behaviour for accessing oral health services:381
"Then you never used to go to the dentist, they used to come around the382
school, this is going back a long time nineteen fifties and sixties. … And then383
most of the time they just pulled your teeth out.  That was, they never did any384
fillings or anything they just looked at your teeth and if they didn’t like the look385
of it, they just pulled out your teeth.” (P14)386
Patients acknowledged the importance of good oral health and reported making387
efforts to try to help their children to maintain good oral health:388
“I mean my kids so soon as they were old enough, like two or three, I would389
take them, we would take them to a dentist just to get them used to a dentist,390
because I think fear of dentists...” (P14)391
Many patients reported that maintaining their oral hygiene was more difficult on the392
days with flare-ups:393
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“If I have a bad flare-up of arthritis, I can’t … and I miss it and I am not able, I394
don’t have the strength to hold my electric toothbrush, because it is quite395
heavy” (P9)396
“If my shoulder hurts then it’s … it can be a bit difficult to brush.” (P13)397
Even holding the toothbrush could be challenging for some patients:398
“I could about hold it, I haven’t got many teeth left anyway. It’s my fear is399
dentists.” (P2)400
Participants mentioned the importance of developing a relationship based on trust401
with their dental care provider. This played an important role in their attitudes towards402
oral health and their behaviours in seeking oral health care services:403
“Well I am concerned that my dentist hasn’t done what needed to be done to404
save my teeth from breaking." (P13)405
Respondents reported being afraid of needles and consequently being afraid of406
dentists. Some patients stated that they would prefer to have extractions instead of407
restorative treatments.408
“I suppose out would be the best at my age I suppose out, you know.” (P2)409
When participants were asked about the way, they felt regarding their oral health,410
and how they regarded the visit to their dentist, many patients (particularly the more411
elderly) reported negative attitudes. Younger patients on the other hand reported412
that they would prefer to keep their natural teeth and have them treated.413
As the discussions continued and patients described their comorbidities secondary414
to RA and how oral health fitted on their list of health care priorities, they also415
expressed their views regarding the outcomes that matter the most for them with416
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regards to their quality of life and wellbeing. Amongst the most important health417
related outcomes considered by the patients were autonomy, mobility and lack of418
pain.419
One of them mentioned how she needed to plan her everyday activities depending420
on whether or not she had a flare-up:421
“You know, where before I used to think nothing of it, I would go off and do422
what I needed to do.  Now, I can’t do that, if I’m in pain I have think right I can423
only do one shop today, or I can’t walk that far today.” (P12)424
Other stories were similar:425
 “Health, mobility that’s very important to me that my feet were not as426
compromised as my hands.  Oh, that is very, absolutely I would tie those two427
together.” (P3)428
“The difficulty I was facing whilst I was working was the inability to hold a pen429
properly …. And work and a computer.  Erm, sitting down meant that my joints430
got really stiff, my knee joints and my back. And my feet and as a431
consequence mobility as I say became very bad… I couldn’t get upstairs to432
the upstairs offices.” (P10)433
Personal mobility and the ability to keep their independence were key priorities for434
this patient population. This was also highlighted through the potential barriers that435
hindered study participation.436
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Barriers for study participation437
The interviews explored the reasons why some patients would be reluctant to438
participate in the OPERA study to identify potential barriers that could be addressed439
by the research team. Several patients reported having negative experiences with440
dentists in the past and this discouraged them to participate in our trial –441
“Yeah, I, I think I woke up under the gas. And, I was there was blood all over442
the place and I was only about this high. At school. And I never went again. I443
stopped going for a long time” (P20)444
The location of the Dental Hospital was mentioned as a hindering factor by several445
patients:446
“That was because it was the Dental Hospital and I find it difficult to get from447
my part of the town to the Dental Hospital.” (P2)448
“It is a bit far away, you know the other side of town but they are moving to a449
new hospital shortly which will be more accessible, yes.” (P18)450
Due to classic features of RA such as mobility problems, fatigue and morning451
stiffness as well as logistic issues with the traffic from their homes to the location of452
the Dental Hospital, they found that without help, they could not attend their clinical453
appointments.454
Besides the location of the Dental Hospital, patients mentioned forgetfulness and the455
overlap of their dental appointment with other medical appointments as being456
important hindering factors for study participation.457
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Removal of barriers458
In order to address these, the participants were asked to suggest potential solutions459
for these problems. Some of the hindering factors were addressed by the research460
team, as described in the methodology section: patients received phone call461
reminders about their appointments and those patients that required assistance for462
getting to the Dental Hospital, received support in arranging the travel logistics463
around getting to their appointments.464
"Because as I say I wouldn’t have been able to undertake the study unless I’d465
have had payment for transportation." (P10)466
Financial incentives were set in place to compensate for the loss of time and logistics467
for the research and treatment visits. As all patients are unique and so is their468
situation and their experiences, some patients did not feel that financial incentives469
should encourage patients study participation:470
That always seems to help I did a lot of groups and the financial side of it isn’t471
a big thing to me.  When I did the conferences, it was all about expenses I472
was happy for my expenses to be paid, but a lot of the groups I also did erm,473
it would be like an interview, but there would be ten of us and we would sit474
around and the discussion would be recorded and you usually found that all475
those groups would be full because people were getting financial…. they were476
being paid for it basically, but you would find that they were all full, all of them.”477
(P5)478
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Some patients reported that they suffered from dental anxiety and indicated that the479
only way they would participate in the study would be if the screening and treatment480
would be done under general anaesthesia:481
“I mean I did say to my son because he keeps telling me off he says, “Mom,482
you really need to go and get your teeth sorted… And I said, I will go if they483
can put me to sleep”. If they can knock me out…. Yeah. I said that’s the only484
way I would have it done.” (P12)485
The control arm486
The control arm in our study received the same treatment as the intervention group487
but with a delay of six months. Patients had very diverse views with regards to the488
how long it was acceptable to delay their treatment. Some of them preferred to have489
no delay at all and some were happy with a delay of up to a few years.490
One of the patients who declined trial participation considered that treatment should491
be delivered immediately without any delay:492
“I think it should be done straightaway…I don’t think you should wait because493
with your mouth everything that goes in your stomach goes into your mouth494
so your gums are one of the main ones really aren’t they? So, I think you495
know, it should be earlier than six months.” (P6)496
The majority of patients, however, felt that a delay of six months to their treatment497
would be acceptable whilst more than that might influence them to seek treatment498
elsewhere.499
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“Oh, I think it’s six months… Six months would be alright…Well, perhaps 12500
months is, I’m 84 don’t forget.” (P2)501
This view was shared by the majority of patients:502
“I was hoping not to be in the delayed group, but as I am in the delayed group503
then I leave it to you erm to help me as best you can… I wouldn’t like the504
longer waiting time.” (P15)505
The intervention506
All patients who received the intervention, both in the immediate treatment group as507
well as in the delayed treatment group reported having a positive experience508
concerning to the intervention.509
“I’m really pleased actually that erm doing this study because erm had it not510
been for that, this could have gone on and on and it might have got to a really511
bad situation with my gums and I wouldn’t have known so I am really pleased.”512
(P11)513
They highlighted the importance of being kept informed about the progression of the514
study and the protocol and having pleasant interactions with the research staff515
Yeah, they have been good, I think the experience has been good.  You staff516
have been really helpful and I am aware of what is happening every time I517
come and see you.  The hygienist was great, she explained what she was518
going to do and what she expected to do in future, so I think it has been a519
really good experience as well and eye opening as well. " (P5)520
This view was shared by all the patients who received the intervention:521
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“She made me feel so comfortable and it’s embarrassing as well when you522
go to dentist... I find I get embarrassed. And because of the state of my teeth.523
I didn’t feel at bit like that from the moment. I met the hygienist and I felt quite524
confident that she was confident. She knew what she was doing. She525
explained everything. And she told me if anything hurt or to stop, to stop her.526
I just felt so comfortable with her… I would do it all over again.” (P21)527
Discussion528
Most studies investigating the associations between periodontitis and RA have used529
quantitative methodologies (Al-Katma et al. 2007; Pinho Mde et al. 2009; Ribeiro et530
al. 2005). OPERA was a mixed methods feasibility study with a nested qualitative531
component. We aimed to explore the acceptability of our study protocol and532
understand RA patients’ experiences and perspectives about accessing oral health533
care services. Furthermore, we gained some valuable insights into the place of oral534
health on their list of priorities, identified barriers and facilitators for study535
participation and gathered patients’ views about the intervention and about being536
randomized to the control arm.537
A large amount of the data regarding the oral health status of older people in England538
is generated from surveys of people living in residential and nursing care homes.539
This represents only a minority of the elderly population and has led to a gap in our540
knowledge and understanding of the dental treatment preferences of this age group541
(Public Health England 2015). Some data suggests that for some of the older542
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patients aesthetics are less of a priority and comfort and lack of pain are considered543
more important (Lord et al. 2015).544
To our knowledge, our study is the first one to look at oral health preferences in545
patients with rheumatoid arthritis and at barriers and facilitators for participation in a546
dental trial for this patient group.547
Our sample was diverse and we purposefully included patients from all the possible548
groups involved in the study: 1. Those who declined trial participation; 2. Those who549
were found ineligible for randomization after screening; 3. Patients who were550
randomized to intervention arm and 4. Patients randomized to control arm. We also551
aimed to include patients of both genders and with different durations of RA552
diagnosis.553
We have found that patients’ prior experiences, values and priorities tend to have a554
strong impact on shaping their choices for accessing different health care services.555
RA patients’ treatments require a holistic approach and whilst their rheumatologic556
care often takes into account their different systemic comorbidities, oral health is557
commonly missed out from this picture. Patients identified a set of barriers and558
facilitators that can influence their participation in an interventional study. Some of559
these barriers were related to patients’ limited mobility and logistic difficulties560
associated with getting to their dental appointments.561
Our patients’ main concerns appeared to be represented by the ability to have as562
“normal” a life as possible - to live independently, autonomously and pain free. These563
findings are in line with the literature with regards to RA patients with multimorbidities564
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and how these shape their choices and priorities in terms of accessing health care565
services (Malm et al. 2017; Ward et al. 2007).566
Our patients described their personal experiences regarding RA and the impact of567
this condition on their quality of life. They reported how the condition affected their568
physical and emotional well-being as well as the influence it had over their socio-569
economic status as a consequence of the reduction of work and/or early retirement570
based on disability.571
Although many participants acknowledged the importance of good oral health and572
its potential impact on general health, when compared to RA and the other573
comorbidities that they have to live with, oral health was not a high priority.574
The patients identified a number of hindering factors that might impact on their ability575
for study participation and some of these factors were addressed by the research576
team with adaptations of the study protocol.577
In many cases, patients reported that they had to balance their life around the578
treatment they received for RA and for their comorbidities: this involved multiple579
medications, hospital visits, etc. The overall burden of RA and of the associated580
comorbidities over the quality of life of these patients could be quite overwhelming.581
Compliance with regular oral hygiene maintenance is key to maintaining good oral582
and periodontal health but it can become an extra burden for this cohort, especially583
on the days when they are dealing with flare-ups caused by their rheumatoid584
condition. Patients who struggle with high burden of debilitating systemic585
multimorbidities, perhaps unsurprisingly, reported that oral health was a not key586
priority for them.587
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We have also identified a number of limitations to this study. This cohort presented588
a median disease duration of 19 [12, 25] years. We acknowledge that the initial589
therapeutic options and approaches at the time of their diagnosis were quite different590
from those of today. Therefore, we can hypothesise that disease progression in this591
cohort could be significantly different compared to a cohort with a more recent onset592
of RA. This could potentially lead to different findings in a cohort with current early593
RA. When we developed the protocol for the randomized controlled trial, we aimed594
to include patients diagnosed with RA who were on stable treatment with disease-595
modifying antirheumatic drugs (DMARDs) for at least 2 months in order to reduce596
the likelihood of potential confounding factors caused by medication changes. It is597
often the case for early diagnosed RA patients to change classes of drugs and598
dosages, therefore after discussing this issue with rheumatologists in the research599
team we decided that in order to meet this goal we focus the recruitment on patients600
with stable established RA.601
From a public health perspective, the burden of non-communicable diseases (NCDs)602
is becoming more and more pressing on the limited resources available for national603
health systems. It is perhaps time to consider new, creative ways of developing care604
packages that may include oral health care for patients with NCDs. This idea is605
supported by the American Diabetes Association as well as by the French National606
Authority for Health, which recommends the inclusion of a comprehensive607
periodontal examination as part of the referrals for initial care management in608
diabetic patients (American Diabetes Association 2018; Haute Autorité de Santé609
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2014). A similar approach may have beneficial effects for patients with other NCDs610
such as rheumatoid arthritis, cardiovascular disease, kidney disease, etc.611
The nested qualitative component of the OPERA trial provided an insight into612
rheumatoid arthritis patients’ experiences and perceptions with regards to oral613
health. Our study also highlighted some of the potential barriers and facilitators for614
participating in a periodontal interventional study in this patient population. We hope615
that these findings will support the design of larger interventional periodontal studies616
in patients with rheumatoid arthritis.617
618
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